912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)

912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; pp. S807 - S808
Main Authors: Gruenwald, V., Graeven, U., Ivanyi, P., Dietz, A., Hahn, D., Hackenberg, S., Kasper, S., Fietkau, R., Moulin, J-C., Pink, D., Schaaf, M., Klinghammer, K.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.1322